Chongqing Weilibao Biotechnology Co., Ltd. is a subsidiary of the overseas Weilibao Group. It is a high-tech enterprise based on advanced international biomedical technology, led by independent innovation, and integrating the research and development, production, sales, and technical services of clinical diagnostic antibodies and reagents and tissue-engineered skin. Over the past 10 years, the company has invested in and incubated multiple heavyweight projects with leading levels in the global industry, and has cooperated deeply with many domestic hospitals. It has participated in 3 major 863 scientific research projects, currently owns 6 national invention patents, and another 3 patents are under public notice.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows